The latest on the coronavirus pandemic and vaccines

Dr. Francis Collins, director of the National Institutes of Health

For some people, symptoms that persist months after getting sick with Covid-19 could become a chronic illness, Dr. Francis Collins, director of the National Institutes of Health, said Monday.

“That is cruel. That is just one more heartbreak that we didn’t see coming,” he said. “I promise you we are all in on this. There will be no stones left unturned. We’re going to figure it out.”

NIH recently launched an initiative aimed at better understanding the long-term consequences of Covid-19 and how to help the people who experience them.

“When you consider we know 28 million people in the United States have had Covid, if even 1% of them have chronic long-term consequences, that’s a whole lot of people, and we need to find out everything we can about how to help them,” Collins said.

“If any organization on the planet can figure this out, it’s NIH,” he added.

The Senate could move as soon as this week to pass their own version of President Biden’s $1.9 trillion Covid relief bill.

That plan will, of course, look a little different than the House bill as it won’t include the $15 an hour minimum wage. It also is not going to include the so-called Plan B drafted by Senate Finance Committee Chairman Ron Wyden that would have penalized corporations that didn’t increase wages on their own. That plan faced pushback in the Democratic caucus.

Democrats in the House and Senate are racing to enact a Covid relief bill by March 14, when key expanded unemployment benefits expire.

Senate Majority Leader Chuck Schumer said today that the Senate will take up the American Rescue Plan “this week.”

Here’s a look at the legislation’s next steps:

This plan is subject to change, but this is what we are looking at for timing.

Read more about the latest on the Covid relief bill here.

President Biden and Senate Democrats talked about “targeting” the Covid relief package today but not reducing the overall price tag of the $1.9 trillion plan, according to Democratic Sen. Jon Tester who attended the virtual meeting Monday on the legislation’s next steps.

The House passed a version of the Covid-19 stimulus bill early Saturday morning, and it is now set to move to the Senate.

Tester said that Biden was mainly in listening mode as Democrats proposed certain changes that could be made through the amendment process.

Tester ultimately predicted there would be “modest” changes made.

One of the items moderate Democrats are looking at to “target” in the coronavirus relief bill is limiting federal unemployment benefits from $400 a week to $300 in an effort to save money and extend the program longer.

The House bill’s federal unemployment program runs through August, but Democratic moderates are arguing the benefit could go longer if the weekly benefit was less. The goal would be to run it to the end of the year, according to one aide familiar with the discussions.

That could face pushback from the rest of the caucus. It’s still unknown on whether it’s really an option, but it’s a sign of moderates trying to reshape pieces of this bill.

Democratic Sen. Ron Wyden, who chairs the Finance Committee, also told CNN that he’s pushing to include in the bill an extension of jobless benefits for an additional month so they can expire in September rather than in August when senators and House members are on their summer recess.

And as CNN’s Ryan Nobles reported earlier, more money for broadband is also something Democrats are pushing for.

More than 200 commercial and tribal casinos have reopened smoke free during the pandemic, including every casino in New Jersey, the US Centers for Disease Control and Prevention reported Monday.

Before Covid-19, this kind of public health momentum in casinos would not have been possible, Brian King of the CDC’s Office on Smoking and Health said during the CDC’s weekly partner call.

All casinos in New Jersey, which includes Atlantic City, have adopted smoke-free policies, King said.

“Seeing that implementation of a broad public health policy in this environment at the state level of a major hub for gambling and casinos is very important,” King said. “It’s definitely a public health win and shows an added benefit of not only protecting workers but also patrons.”

The benefits of smoke-free policies go beyond reducing secondhand smoke exposure, which has been shown to increase risk of stroke, lung cancer and heart attack in adults. Smoke-free policies also encourage more people to stop smoking and keep people from starting at all, King said.

The question remains if these casinos will remain smoke-free when other restrictions ease and more people become vaccinated.

“If all these casinos remain smoke free even post Covid-19, this could have an immeasurable in terms of not only protecting the public who attend these venues, but also workers who are working eight hours or more per day in these environments” King said.

A pop-up Covid-19 testing site is shown in a neighborhood among those that have seen some of the highest number of city deaths on February 23, in the Queens borough of New York City.

The US has recorded an average of about 1.5 million Covid-19 tests per day over the past week, according to data from The COVID Tracking Project.

That’s about 26% fewer than the average in mid-January, when the US hit a peak seven-day average of more than 2 million tests reported on Jan. 15.

The decline in new tests reported nationally had been rather consistent since hitting that peak. But over the past seven days, the number of new tests reported has started to tick back up.

The average of about 1.5 million tests per day over the past week is a 14% increase over the average of about 1.3 million tests per day the week before.

Even as case rates drop, experts have stressed the importance of testing as a way to stay ahead of outbreaks, particularly with the new variants in the mix.

Contract tracing, which requires sufficient testing, is also one of five key mitigation strategies outlined by the US Centers for Disease Control and Prevention in school reopening guidance.

More on the testing data: Reported test counts are estimates. Also, states do not all report tests consistently. Some include both viral (PCR) and antigen tests, and some report based on the number of people tested as opposed to the number of specimens tested.

Syringes used to administer the AstraZeneca Covid-19 vaccine, at the office of a general practitioner in Gragnague, France, on February 26.

France has extended the upper age limit for use of the Oxford/AstraZeneca coronavirus vaccine, now approving use of the vaccine in 65 to 75 year olds with serious health conditions, the country’s health minister announced Monday. 

The decision comes after a previous warning from the government that AstraZeneca’s Covid-19 vaccine should only be administered in people under the age of 65, citing a lack of clinical data on its efficacy for older people.

Speaking to France 2 TV, the health minister said the French National health authority now considers all vaccines available in France, including the AstraZeneca, Pfizer and Moderna vaccines, to “have an effectiveness qualified as ‘remarkable’ in protecting people from the risks of serious forms of coronavirus.” 

While coronavirus restrictions are still in place across the country, Veran also suggested that the government would consider easing measures over the coming weeks. 

“We obviously hope that in four to six weeks, we can have more freedom,” Veran said. 

“We did this last year. Spring is less conducive to the circulation of the virus. We vaccinate, we protect the most vulnerable, we keep our fingers crossed,” he added. 

Two doses of coronavirus vaccine protect people better against coronavirus variants than just one dose, CDC experts said Monday.

The B.1.351 variant first seen in South Africa has the most worrying effects on the ability of vaccines to produce an immune response, the CDC’s Dr. Heather Scobie told a meeting of the CDC’s Advisory Committee on Immunization Practices.

But there are concerns about the B.1.1.7 variant first seen in the UK, as well as a variant common in Brazil known as P2.

She said the CDC has reviewed many of the studies – some published, others released as unreviewed pre-prints – on how the variants allow the virus to evade immune responses.

“Five studies have shown that postponing the second mRNA dose may leave some people less protected against the SARS-Cov-2 variants,” Scobie told the ACIP meeting. The Moderna and Pfizer/BioNTech vaccines are mRNA vaccines.

“All of the studies showed improved neutralization of B.1.1.7 and B.1.351 after the second vaccine dose,” she added. “In a few studies, people who had recovered from Covid-19 and received one vaccine dose had moderate protection against B.1.351.”

There are indications that people’s immune responses grow stronger over time after vaccination, Scobie said.

 “Antibody responses to B.1.1.7 and B.1.351 improved slightly by week three,” she said. 

Real-life studies also give some clues about how well the vaccines will protect people from the variants. 

“The Pfizer vaccine was shown to have high real world effectiveness of 86% against symptomatic and asymptomatic disease in the UK and 84% against symptomatic disease in Israel during times when B.1.1.7 was prevalent,” Scobie said.

Protection provided by the one-dose Johnson & Johnson vaccine varied from 74% in the US to 66% in Brazil at a time when most cases were caused by the P2 variant. During clinical trials in South Africa, where the B.1.351 variant was almost the only circulating virus, Johnson & Johnson vaccine efficacy was 52%. But that’s against mild to moderate disease. It provided between 73% and 82% efficacy against severe disease no matter which variant was the most common.

“Importantly, the Janssen vaccine demonstrated similar vaccine efficacy against severe, critical disease across all three countries,” Scobie said.

The first shipment of Covid-19 vaccines sent through the COVAX program to Latin America landed in Colombia on Monday afternoon, the Pan American Health Organization (PAHO) announced.

The shipment of 117,000 Pfizer vaccine doses landed at El Dorado Airport in Bogota in the afternoon local time, the Colombian government said in a statement. The doses will be transferred to Ministry of Health warehouses to be stored.

COVAX is an entity run by a coalition that includes the Vaccine Alliance known as Gavi and the World Health Organization (WHO), and is funded by donations from governments, multilateral institutions and foundations.

It aims to buy coronavirus vaccines in bulk and send them to poorer nations that can’t compete with wealthy countries in securing contracts with the major drug companies.

Colombia now has at least 409,620 vaccine doses; the country previously received 100,620 doses through a deal with Pfizer and 192,000 doses from Sinovac.

Colombia expects to receive a total of 61.5 million doses of the vaccine, 20 million doses through the deal with COVAX and 41.5 million from various pharmaceutical companies, a government statement said. 

COVAX shipments are still expected in other Latin American countries including Argentina, Brazil, Peru, Mexico, among many others.

To achieve herd immunity, the Colombian government hopes to vaccinate 70% of the country’s population, around 35,734,649 people. 

Colombia currently has at least 2,251,690 confirmed cases of Covid-19 and 59,766 recorded deaths, according to data from Johns Hopkins University.

Senate Majority Leader Chuck Schumer said that “this week” the Senate will take up the $1.9 trillion American Rescue Plan.

Some context: The House passed their own version of the Covid relief bill early Saturday morning. If the Senate passes their version of the bill by the end of the week, that gives the House time to re-pass the new version in their own chamber.

It also gives President Biden time to sign it and gives states an opportunity to readjust their unemployment benefits with the increased benefit. Biden and Democrats are rushing to meet their deadline of having enacted the bill by March 14 when a weekly federal enhancement in benefits is scheduled to expire.

Stools stacked on desks inside an empty classroom at Collins Elementary School in Pinole, California, on December 30, 2020.

Lawmakers have reached an agreement to return most California students to classrooms by the end March.

The agreement combines proposals from Gov. Gavin Newsom and from California’s legislature and will provide up to $6.6 billion to return schools to in-person learning.

Of that, $2 billion will be made available to those schools that bring students back by March 30.

Schools will be eligible for their part of the $2 billion incentive once they resume classes for at least those students in transitional kindergarten through second grade. 

The rest of the funding, $4.6 billion, is aimed at helping schools make up for lost learning time, or as Newsom calls it, “reimagining the school year” which could include longer school days and/or summer school. 

Ultimately, the reopening decisions lay with the superintendents of each district, not the state. The funding, which is mainly earmarked for personal protective equipment, improved ventilation, and other safety protocols, may well provide the incentive districts need.

Some teachers unions, including United Teacher Los Angeles (UTLA), which represents educators in Los Angeles Unified School District (LAUSD), have balked at resuming classes until teachers have the chance to be vaccinated.

Starting today, the pool of those eligible to receive a vaccine in Los Angeles has expanded to include educators.

LAUSD, the nation’s second largest district, has secured 25,000 vaccine doses for teachers and staff, which will be initially focused on inoculating those already working at school sites, preschool, and elementary teachers, according to Superintendent Austin Beutner.

In the meantime, UTLA’s membership is voting today on whether they will agree to return before staff is provided with full access to vaccinations and safety conditions are in place.

The agreement specifies that districts can resume class regardless of whether the unions sign off.

The three Federal Emergency Management Agency vaccination sites in Texas are expected to receive 24,000 doses of the Johnson & Johnson Covid-19 vaccine on Tuesday, according to Lara Anton, a press officer for the Texas Department of State Health Services.

It’s not yet clear if the doses will be administered on Tuesday.

More than 200,000 Johnson & Johnson doses are expected be available to Texas for next week’s allocation, Anton said.

Of the 3.9 million doses of the single-shot Johnson & Johnson vaccine being distributed by the federal government, the Association of Immunization Managers said Monday that they will be distributed as follows:

The US Food and Drug Administration on Monday granted emergency use authorization to the Quidel QuickVue At-Home Covid-19 Test.

Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a statement that “The FDA continues to prioritize the availability of more at-home testing options in response to the pandemic.”

Here are some key things to know about the at-home test:

Rapid antigen tests have been shown to be less accurate than RT-PCR tests, which are considered the “gold-standard” of diagnostic testing.

In a press release, Quidel said the test can return results in as little as 10 minutes, and that positive test results match PCR tests 84.8% of the time; negative test results match PCR results 99.1% of the time.

The sample swabs are placed in a test tube along with a test strip. Colored lines on the test strip indicate a positive or negative test result, similar to a home pregnancy test.

In a separate news release Monday, the National Institutes of Health announced it is evaluating the use of Quidel’s QuickVue test with a smartphone app. The agency says it has enrolled more than 200 participants in the study, which requires them to use the test daily for two weeks.

The NIH says that as at-home tests become more widely available, it believes companion apps will play a role in tracking symptoms, administering tests and reporting results to public health authorities and health care providers.

“Understanding how individuals interact with these apps and where they find value in them will inform future efforts to advance at-home COVID-19 testing,” the NIH said in a statement.

The US military has administered 1,144,697 doses out of 1,275,925 doses delivered to the military so far. At least 735,000 of those are initial doses, 409,000 are second doses, Pentagon spokesperson John Kirby said. 

The US military expects to get doses of the Johnson & Johnson vaccine delivered to them in “the next week or so,” now that it has been approved by the FDA for Emergency Use Authorization, Kirby said.

Kirby acknowledged that the Secretary is aware of vaccine hesitancy in some pockets of the military, particularly “cultural and community concerns,” he said.

Right now, the Pentagon has not decided whether or not to make the Covid-19 vaccine mandatory when it does receive full authorization from the FDA. The Pentagon cannot make the vaccine mandatory currently because it has been authorized under emergency use by the FDA.

“These are still under emergency authorization, and so right now, they are not mandatory. Obviously, we’re thinking about what happens when they become FDA approved,” Kirby said.

A person receives a dose of a Covid-19 vaccine in Inglewood, California, on February 26.

Nearly 77 million doses of Covid-19 vaccine have been administered in the United States, according to data published Monday by the US Centers for Disease Control and Prevention. 

The CDC reported that 76,899,987 total doses have been administered – about 80% of the 96,402,490 doses delivered.

That’s about 1.7 million more administered doses reported since yesterday, for a seven-day average of more than 1.8 million doses per day.

More than 15% of the population – about 50.7 million people – have now received at least one dose of vaccine. Nearly 8% of the population – nearly 25.5 million people – have been fully vaccinated with both shots, CDC data shows.

Data published by the CDC may be delayed, and doses may not have been given on the day reported.

From left, Senate Majority Whip Dick Durbin listens to Senate Majority Leader Chuck Schumer speak at a news conference on February 23.

Senate Democratic leaders are urging their caucus to stick together and fend off GOP amendments that could alter key elements of the $1.9 trillion relief plan when it heads to the floor later this week, a plea aimed at keeping together a fragile Democratic coalition in order to send the bill to President Biden’s desk by mid-March.

Senators are walking into a legislative minefield later this week since the relief bill is being considered under budget reconciliation rules that allow a free-flowing amendment process, meaning senators can force votes on as many amendments as they like. That means if two Democrats break ranks, they could amend the bill with the backing of 49 Republicans.

But Democratic leaders want their caucus to hold the line against amendments that could alter the core of the bill and ultimately derail the chances of getting the sweeping measure out of both chambers by March 14 — when jobless benefits are set to expire for millions of Americans.

Asked if he wanted his caucus to hold the line against GOP amendments, Senate Majority Whip Dick Durbin told CNN: “Certainly [against] any amendments that we think will be disruptive of the reconciliation process — maybe more.”

Durbin added of the GOP amendments: “There are some that could be lethal. So we have to take it very seriously.”

It’s unclear which amendments could peel away Democratic support, but party leaders and the White House have their eyes in particular on a handful of their more centrist members, including Sens. Joe Manchin of West Virginia, Kyrsten Sinema of Arizona and Angus King of Maine.

Whether there could be some changes around the margins of the bill remain to be seen. And already the Senate is poised to make one major change: Scrapping the $15 federal minimum wage included in the House-passed bill since it was ruled by the Senate’s parliamentarian as outside the scope of the chamber’s rules of budget reconciliation.

Some House liberals want the presiding officer of the Senate, potentially Vice President Kamala Harris, to simply ignore the parliamentarian’s ruling and keep the minimum wage in the bill.

But Durbin threw cold water on that idea, which is also opposed by a number of senators in both parties and by the White House.

Yet pursuing the wage hike outside of budget reconciliation would require 60 votes to overcome a GOP filibuster, something highly unlikely to succeed.

Given the divisions within the Senate Democratic Caucus over the $15 hourly wage mandate, Durbin conceded that the parliamentarian’s decision made passage of the overall bill “less complicating,” while calling the ruling “disappointing.”

White House press secretary Jen Psaki said on Monday that President Joe Biden is not considering sharing part of the US coronavirus vaccine supply with Mexico.

On Sunday, CNN reported that Obrador was expected to ask Biden to share some of the US Covid-19 vaccine supply, according to a Mexican government official briefed on plans for the conversation. 

Ahead of a virtual bilateral meeting between Biden and Mexican President Andres Manuel Lopez Obrador Monday afternoon, Psaki was asked whether Biden is considering sharing part of the supply with the country. 

The press secretary said the Biden administration is focused on economic recovery and ensuring that Mexico and Canada are safe enough to open their borders to the US.

“(T)he administration’s focus is on ensuring that every American is vaccinated. And once we accomplish that objective, we’re happy to discuss further steps beyond that,” Psaki added.

Johnson & Johnson’s single-dose coronavirus vaccine is now the third Covid-19 shot approved for use in the US, with some 3.9 million doses to be distributed as early as Tuesday.

CNN’s Pete Muntean was live at a UPS facility in Kentucky as the new vaccine rolls out, answering your questions.

Watch more:

Video Ad Feedback

5946dc34-e8cb-4bbe-adb7-3f756e5007d0.mp4

08:18 - Source: cnn

President Biden arrives at the Roosevelt Room of the White House to address the nation about the Covid relief bill on February 27.

President Joe Biden continues to engage with the Senate amid this week’s efforts to pass his top legislative priority, a $1.9 trillion Covid relief bill. The clock is ticking to get the bill passed and signed into law before unemployment insurance expires for millions of Americans on March 14.

White House Press Secretary Jen Psaki said Monday the White House is “evaluating day by day what the needs are” for Biden’s engagement with Democrats, as well as Republican senators that could be persuaded to vote for the package. 

Biden will be meeting via Zoom “with a number of Democratic senators this afternoon,” she said.

Her comments come after White House director of public engagement Cedric Richmond told Axios on HBO that he is still meeting with Republicans and said that “possibly, maybe even probably,” a Republican will vote for it.  

Psaki also said Monday that the White House does not intend to challenge a ruling from the Senate parliamentarian that will not allow the $15 minimum wage provision to be in the Senate version of the bill. 

A decision for Vice President Kamala Harris to override the parliamentarian’s ruling would “also require 50 votes,” and is “not an action we intend to take,” she said.

Psaki reiterated Biden’s campaign promise to raising the minimum wage and suggested they will be looking for the “best vehicle” to do so. 

The first UPS truck carrying the Johnson & Johnson vaccine just arrived at the carrier’s Worldport hub in Louisville, Kentucky. The company says deliveries will start Tuesday for the eastern half of the country.

More trucks carrying the vaccine are expected to arrive at the facility throughout the day Monday.

UPS says two people will unload vaccine shipments by hand onto more than 150 miles of conveyer belt where machines will sort vaccine packages in 13 minutes time. Packages will then be loaded onto UPS cargo planes along with regular, everyday packages— even though vaccine shipments are getting priority over other packages.  

UPS head of healthcare Wes Wheeler told CNN in an interview that the network has plenty of capacity to carry the new vaccine. The company has already shipped tens of millions of Pfizer and Moderna doses. 

Some more context: The White House said Monday 3.9 million doses are going out in this initial wave of shipments. Johnson & Johnson said Monday the goal is to distribute 20 million doses of the vaccine by the end of this month.

Boxes containing the Johnson & Johnson vaccine are loaded into a truck in Shepherdsville, Kentucky, on March 1.

Dr. Marcella Nunez-Smith, who chairs the White House coronavirus equity task force, told CNN Monday that while there are benefits to the newly approved Johnson & Johnson single-dose Covid-19 vaccine that make it appealing for treating marginalized and hard-to-reach communities, “overall, you know, we do think that the distribution again should be even across communities.”

Over the weekend, the CDC’s Dr. Sara Oliver told the Advisory Committee on Immunization Practices that a single-dose vaccine has an advantage, particularly in settings where a second dose “would be challenging,” and could be used to help protect the homeless, people in the justice system, and those with limited access to health care like people who are homebound or live in rural areas.

Still, to ensure that the vaccine is spread across all communities, Dr. Nunez-Smith told CNN, “we will be tracking biometrics such as zip code and social mobility to see where vaccines are going.”

Should it arise that any one vaccine is being deployed in a disproportionate manner to one community over another, Nunez-Smith said, “we’re here provide support and technical assistance to pivot and intervene and correct if and when needed.”